Advertisement
| signal transduction and targeted therapy impact factor: Handbook of Oncobiology: From Basic to Clinical Sciences R. C. Sobti, Nirmal K. Ganguly, Rakesh Kumar, 2024-05-14 This Handbook on cancer biology comprehensively reviews the current status of the oncobiology of major cancer types, cancer detection and treatment strategies, principles and processes of cancer drug development, and nanomedicine and other emerging cancer medicine applications to cancer diagnosis and treatment. The book also provides practical and implementable nutritional guidance in cancer prevention, treatment, and quality of life for cancer survivors. It discusses pharmacogenetics strategies for predicting cancer prognosis and treatment exposure, response, and toxicity. Further, it presents bioinformatics approaches for predicting anti-cancer drugs and drug combinations based on the multi-omic data, including transcriptomics, toxicogenomics, functional genomics, and biological networks. The Handbook also examines major factors and pathways that regulate cancer stem cells development and discusses potential targeted therapy for cancer stem cells. The book explores the application of the CRISPR/Cas9-based gene-editing technique in basic cancer research, diagnosis, and treatment of cancer. This Handbook is an invaluable source for oncologists, researchers, public health specialists, epidemiologists, and policy makers. |
| signal transduction and targeted therapy impact factor: Cancer Signaling Christoph Wagener, Carol Stocking, Oliver Müller, 2016-08-12 Cancer, which has become the second-most prevalent health issue globally, is essentially a malfunction of cell signaling. Understanding how the intricate signaling networks of cells and tissues allow cancer to thrive - and how they can be turned into potent weapons against it - is the key to managing cancer in the clinic and improving the outcome of cancer therapies. In their ground-breaking textbook, the authors provide a compelling story of how cancer works on the molecular level, and how targeted therapies using kinase inhibitors and other modulators of signaling pathways can contain and eventually cure it. The first part of the book gives an introduction into the cell and molecular biology of cancer, focusing on the key mechanisms of cancer formation. The second part of the book introduces the main signaling transduction mechanisms responsible for carcinogenesis and compares their function in healthy versus cancer cells. In contrast to the complexity of its topic, the text is easy to read. 32 specially prepared teaching videos on key concepts and pathways in cancer signaling are available online for users of the print edition and have been integrated into the text in the enhanced e-book edition. |
| signal transduction and targeted therapy impact factor: Cell Signaling Adeeb Shehzad, 2025-04-17 This book provides a comprehensive understanding of cell signaling, molecular interactions, and their implications for human health and diseases. It introduces fundamental principles underlying cell communication through signaling molecules and their diverse transmission and reception mechanisms, highlighting their role in intercellular communication through voltage- and ion-gated channels, immunological and neuron synapses, and rhinovirus–receptor interaction involved in pathogenesis and disease development. Toward the end, the book highlights the profound implications of altered cell signaling pathways in the inflammation and immune response followed by the progression of various disorders, including cancer, endocrine disorders, and neurological illnesses. It explores the diagnostic and therapeutic implications of cell signaling in targeted therapies, highlighting advanced techniques for detecting signaling molecules and innovative therapeutic approaches to inspire new developments in precision medicine. It serves as an important resource for academics, students, and professionals in the fields of cell biology and biomedical sciences. Key Features: Provides in-depth understanding of cell signaling, exploring its complexities and impact on human health and disease Introduces fundamental principles of cell communication, emphasizing the different signaling molecules and their various transmission pathways Focuses on complex structures and functions of receptors, highlighting their essential role in intercellular communication and regulating cellular behavior Examines the molecular aspects of cell surface adhesion receptors, elucidating protein–protein interactions, signaling cascades, and enzyme–substrate interactions Discusses the impact of cell signaling on inflammation, cancer, and endocrine and neurological disorders |
| signal transduction and targeted therapy impact factor: Drug Development and Safety , 2024-07-10 This book provides a detailed overview covering all aspects of drug development, from synthesis and manufacturing to delivery strategies, and ensuring a thorough understanding of the field. This book will show how new drugs are made. The chapters also give inside information on regulatory authorities so that drugs meet the necessary standards for quality. Drug Development and Safety effortlessly switches over to drug delivery technologies by exploring ground-breaking methods that are changing medicine forever. Controlled-release drug delivery systems represent some of the current breakthroughs while using nanoparticles for treating cancer stands among other recent therapeutic innovations. Each chapter has been authored by a leading scientist or expert in that particular field, and various viewpoints will be presented to provide a fuller understanding of the subjects concerning the safety of drugs. The book will be for chemists, pharmacists, and biologists, and it will be their only guide while navigating the challenging pharmaceutical science terrain. |
| signal transduction and targeted therapy impact factor: Epigenetic Mechanisms in Breast Cancer Therapy and Resistance Sanchita Bhatnagar, 2024-11-25 Epigenetic mechanisms are essential for normal mammalian development and maintenance of gene expression patterns. Disruption of epigenetic processes can lead to altered transcriptional regulation, gene levels, and malignant cellular transformation. Global alterations of the epigenetic landscape are a hallmark of tumorigenesis and metastasis. Conventionally, cancer was thought to be a genetic disease, but recent advancement in the field identified an abundance of epigenetic abnormalities along with genetic alterations. The extensive reprogramming of epigenetic machinery in cancer includes DNA methylation, histone modifications, nucleosome positioning and non-coding RNAs, specifically microRNA expression. Additionally, the reversible nature of epigenetic aberrations has led to the emergence of the promising field of epigenetic therapy, and recent FDA approval of epigenetic drugs for cancer treatment. This book focuses on the epigenetic mechanisms in breast cancertherapy and resistance. It is organized into three sections, including epigenetic mechanisms in breast cancer, targeting epigenetic mechanisms for new therapies, and new and emerging methodologies to study epigenetic alterations in breast cancer. Chapters highlight various epigenetic regulations that prevent breast cancer growth and progression, as well as epigenetic alterations that contribute to breast cancer progression. This text is a useful methodology book for researchers and students interested in epigenetics in breast cancer and the fundamentals of cancer biology. |
| signal transduction and targeted therapy impact factor: Terpenoids Bimal Krishna Banik, Biswa Mohan Sahoo, Abhishek Tiwari, 2022-12-23 This unique volume covers specific aspects of the biological chemistry of terpenoids. It provides extensive information related to classification, general methods of extraction and isolation of terpenoids, synthesis and pharmacological activities of monoterpenoids, synthesis and medicinal uses of diterpenoids, biogenesis of terpenoids, synthesis and medicinal uses of sesqui terpenoids and sesterpenoids. Some terpenes are also classified as diterpene alkaloids. Most of the terpenoids with diverse molecular structures are biologically active and are used for the treatment of various diseases such as cancer, malaria, inflammation, tuberculosis and infection, and this is discussed. Features: Activities and biological relationships of terpenes An accurate assessment of where and what terpenes can lead to Discusses how microbes, in particular the actinomycetales, have well over 400 different gene clusters that produce terpenes Arranged by biological activities and usage Provides information on eukaryotic enzymes that have been shown to be a source of “ethnobotanical” terpenes |
| signal transduction and targeted therapy impact factor: Targeted Interference with Signal Transduction Events B. Groner, 2007-08-09 This book does nothing less than lay out the state of development of tomorrow’s cancer drugs, directed against growth factors, growth factor receptors and intracellular signaling molecules with kinase activities. The sequencing of the human genome and insights into signaling pathways have contributed to the understanding of cancer etiology and the development of new, improved cancer drugs such as Herceptin and Glivec. The deregulation of pathways due to mutated cancer genes provides the conceptual basis for future progress. Will it be possible to derive more efficient cancer drugs? |
| signal transduction and targeted therapy impact factor: Overcoming Breast Cancer Therapy Resistance Zodwa Dlamini, 2024-06-03 This book addresses the pressing problem of drug resistance in the treatment of breast cancer. It provides a comprehensive understanding of the complex mechanisms underlying drug resistance and presents the latest advances in therapeutic approaches to overcome this enormous challenge. The book begins with an introduction to the biology of breast cancer, treatment modalities and the mechanisms of drug resistance. This includes the principles of drug resistance in targeted, immune-, endocrine and chemotherapy. In the following sections, the authors present innovative strategies to overcome drug resistance and new research directions, among others the role of the microbiome in drug resistance, molecular profiling of patients for personalized medical care, and new drug delivery systems. Finally, the book concludes with a discussion of the differences in the prevalence and treatment success of breast cancer between high- and low-income countries. This book is an informative resource for students, researchers, and clinicians in the field of breast cancer research and oncology in general. |
| signal transduction and targeted therapy impact factor: Nanocarrier Drug Delivery Systems Prashant L. Pingale, Sanjula Baboota, Javed Ali, 2024-09-02 Nanotechnology can treat diseases by site-specific and target-oriented delivery of precise medicines. Nanomaterials improve the efficacy of drugs and selective diagnosis. The book covers detection and treatment. It explains the use of nanocarriers for a variety of diseases such as cardiovascular and respiratory diseases, cancer, and ulcerative colitis. It includes topical, transdermal, and ocular drug delivery and combined medication delivery. |
| signal transduction and targeted therapy impact factor: Targeted Therapy for the Central Nervous System Viral Patel, Mithun Singh Rajput, Jigna Samir Shah, Tejal Mehta, 2024-10-07 Targeted Therapy for the Central Nervous System: Formulation, Clinical Challenges, and Regulatory Strategies presents research on various delivery methods of drugs to the central nervous system and brain. This volume examines targeted therapies for neurodegenerative disorders and succinctly outlines the future of drug delivery systems, highlighting significant advancements specifically relating to central nervous system delivery. This book will be of great interest to researchers working in the field of neuroscience and pharmacology as well as clinicians (pharmacists, radiologists, psychiatrists). - Provides a current, thorough means on how drugs are delivered to the neurological system - Figures a connection amongst the physiology of drug delivery pertaining to the central nervous system, fundamentals of drug delivery, and distribution principles - Gives an accounting of clinical trials and regulatory approaches for the formulations targeting brain |
| signal transduction and targeted therapy impact factor: Recent Frontiers of Phytochemicals Siddhartha Pati, Tanmay Sarkar, Dibyajit Lahiri, 2023-04-26 Phytochemicals have been present in human diet and life since the birth of mankind, including the consuming of plant foods and the application of herbal treatments. This coevolutionary interaction of plants and people has resulted in humans' reliance on food and medicinal plants as sources of macronutrients, micronutrients, and bioactive phytochemicals. Phytochemicals can be used as adjuvant agents and sensitizers in traditional antibiotic and anticancer therapy, reducing the potential of selecting resistant microbial strains and cancer cells. Recent Frontiers of Phytochemicals addresses the many processes of potential phytochemical evaluation of known sources, with a focus on phytochemical and pharmacological evaluations, and computational research into the structures and pharmacological mechanisms of natural products and their applications in medicine, food and biotech. - Novel extraction, characterization, and application method for phytochemicals in food, pharmacology, and biotechnology - Colour illustrations and extensive tables with state-of-art information - Covers potential sources of phytochemicals, their extraction and characterization techniques |
| signal transduction and targeted therapy impact factor: Nano-formulation of Dietary Phytochemicals for Cancer Management Nidhi Puranik, 2025-02-24 This book covers various cancer chemotherapeutics, offering research-oriented overviews of phytochemical-based cancer treatments. It contrasts nano-formulated phytochemical delivery with conventional chemotherapy, introducing nanocarriers or bioengineering for poly-chemotherapy and phytochemicals as alternative treatments to reduce resistance. The text elaborates on the nano-formulation techniques and synthesis approaches of phytochemicals as drugs, the targeted drug delivery facilitated by nanocarriers, and subsequent mechanisms of drug release. Additionally, it examines the implications of nano-formulated phytochemicals in cancer therapeutics and their impact on cancer treatment and prevention. By enhancing bioavailability and improving functional qualities through nanoencapsulation, this innovative approach promises significant advancements in cancer therapy. Key concepts include dietary phytochemicals' role in various types of cancer chemotherapeutics, the pharmacological mechanisms of action in prevention and treatment, and strategies to enhance chemotherapy and radiotherapy efficacy. The book also presents preclinical and clinical studies on the efficacy of phytochemicals in cancer treatment. Additionally, it highlights improvements in drug delivery systems using nanotechnology-based dosage forms for herbal drugs. The content is designed for professionals involved in drug development, including chemists, pharmacists, biologists, biotechnologists, industrialists, nanotechnologists, microbiologists, economists, and all disciplines related to cancer treatment and phytochemical-based drug development. Academic students, scientists, and researchers at universities, institutes, hospitals, botanical institutes, pharmaceutical industries, government organizations, and NGOs will find invaluable insights into the application of phytochemical drugs in cancer treatment. By providing a detailed examination of cutting-edge research on nano-formulated phytochemicals for cancer therapy, this book invites readers to rethink traditional approaches to chemotherapy and explore innovative solutions that promise better outcomes for patients worldwide. |
| signal transduction and targeted therapy impact factor: The Textbook of Nanoneuroscience and Nanoneurosurgery Babak Kateb, John D. Heiss, John S. Yu, Ming Hsieh, 2024-11-13 This textbook highlights the exciting field of nanoneuroscience and its potential to transform how we diagnose and treat neurological disorders. The Textbook of Nanoneuroscience and Nanoneurosurgery, dives deep into this emerging field, exploring the latest tools and techniques currently being developed at the nanoscale level. Key areas of focus include: Nanoplatforms: The book explores how scientists utilize materials on a near-microscopic scale for neurosurgery, neurology, and brain imaging applications. Bridging the Gap: Regulatory hurdles for translating research from the lab to real-world use are addressed, paving the way for future advancements. The Future is Now: The book showcases recent breakthroughs already impacting patient care alongside promising areas with significant potential. Collaboration is Key: Insights from over 220 researchers and 5000+ references, along with illustrative figures in B/W and color, provide a comprehensive overview of this dynamic field. With its focus on minimally invasive procedures and the latest regulatory considerations, The Textbook of Nanoneuroscience and Nanoneurosurgery equips researchers and medical professionals with the knowledge to develop groundbreaking treatments for neurological conditions. The text also reviews the latest regulatory guidelines that influence the translation of nanotechnological research from the laboratory to the clinic and the most recent information on biodevices and pharmaceutical spinoffs. It highlights presidential and congressional initiatives and programs that may impact the field soon. Some reviews of the First edition of the textbook. ...a significant contribution to the field of nanoneuroscience and nanoneurosurgery ... the reader will come away with a deeper understanding of the history of nanotechnology and medicine. —Neuroscience This is a monumental first textbook on nanoneurosurgery. ... recommended reading for neurosurgeons, neurologists, neuroradiologists, and neuroscientists involved in research on new techniques for application in neurosurgery. Biomedical engineers and various companies developing instruments and devices would benefit from the wealth of information about trends for the development of new technologies for neurosurgery. K. K. Jain, MD, Basel, Switzerland Phenomenal body of knowledge in this book that would take eons to collate by myself. Every answer to every one of my questions plus heaps more. Essential reading for everyone interested in the field. A must-have! Albert Deme This is an amazing foray into the future of a largely unexplored, but increasingly critical medical domain.....I have learned much from every page of this captivating text, and I highly recommend it to any medical student, researcher, medical professional in the neurosciences, or anyone who has an interest in the human brain and the future of medicine, to gather a glimpse of the incredible and beneficial paradigm shifts that will soon impact the field of neuroscience. Frank Boehm, British Columbia, Canada |
| signal transduction and targeted therapy impact factor: Holcomb and Ashcraft's Pediatric Surgery E-Book George W. Holcomb, J. Patrick Murphy, 2019-04-14 Known for its readability, portability, and global perspectives, Holcomb and Ashcraft's Pediatric Surgery remains the most comprehensive, up-to-date, single-volume text in its field. As technology and techniques continue to evolve, the 7th Edition provides state-of-the-art coverage—both in print and on video—of the full range of general surgical and urological problems in infants, children, and adolescents, equipping you to achieve optimal outcomes for every patient. - Provides authoritative, practical coverage to help you implement today's best evidence-based open and minimally invasive techniques, with guidance from internationally recognized experts in the field. - Features more than 1,000 high-quality images depicting the visual nuances of surgery for the full range of pediatric and urologic conditions you're likely to see. - Delivers comprehensive updates throughout including the latest advances in managing Inguinal Hernias and Hydroceles; Imperforate Anus and Cloacal Malformations; Hirschsprung Disease; Duodenal and Intestinal Atresia and Stenosis; Esophageal Atresia; and more. - Offers access to more than 50 videos that help you improve and refine your surgical skills. New videos cover Fetal Endoluminal Tracheal Occlusion (FETO); Laparoscopic Inguinal Hernia Repair; Robotic Extravesical Ureteral Reimplantation; Laparoscopic Management of Ovarian Torsion; and Laparoscopic Sleeve Gastrectomy. - Enhanced eBook version included with purchase, which allows you to access all of the text, figures, and references from the book on a variety of devices |
| signal transduction and targeted therapy impact factor: The Basics of Cancer Immunotherapy Haidong Dong, Svetomir N. Markovic, 2024-07-05 This comprehensively updated new edition provides patients and their physicians (especially non-oncologist healthcare providers) with a clear and concise introduction to cancer immunotherapy. Unlike traditional forms of cancer therapy, immunotherapy acts by boosting the patient’s own immune system to fight cancer; immunotherapy's unique features make its management, monitoring and side-effects different from those of traditional cancer therapy. Especially novel are the side effects of cancer immunotherapy, necessitating greater awareness for both patients and physicians in order to minimize complications and maximize benefits. The patient-friendly and state-of-the-art knowledge presented in this book will inform patients and their care providers about the benefits and risks of cancer immunotherapy, and help them to understand how immunotherapy would control their unique disease. Researchers and academic professionals in the field of cancer immunotherapy will also find clear, useful information to help them communicate with patients and address unresolved issues. Key features include: Expertise. Editors and authors are scientists and oncologists specializing in cancer immunotherapy, involved in scientific discovery from the early stage of immune-checkpoint inhibitors to today's patient care. Their insights, expertise and experience guarantee high quality and authority in the science, medicine and practice of cancer immunotherapy. Patient-friendly. This book is written specifically for cancer patients considering or undergoing immunotherapy. As an educational tool, this book will help the reader to understand the underlying science, balance the risks and benefits based on both research and clinical facts, and make an informed decision regarding their treatment options. Disease Specificity. Cancer is a complicated disease involving multiple stages and pathology. Its response to immunotherapy is individualized and varies depending on cancer types. The authors’ expertise in treating different types of cancers, including melanoma, lung, kidney, bladder, breast, and lymphoma, provides disease-specific insights in applying immunotherapy to each disease. State-of-the-Art. This edition has been comprehensively updated to reflect recent advances, including detailed coverage of the latest therapies like CAR-T, TIL, immune checkpoint inhibitors and bispecific T cell engaging antibodies, and dedicated chapters on breast cancer, solid organ transplant recipients, GI and genitourinary malignancies, and resistant cancer. Aimed at patients and non-oncologist care providers as a resource when seeking immunotherapy as a treatment option Detailed focus on various cancers provides disease-specific insights, clinical studies, and risk/benefit analysis Comprehensively updated to address the latest immunotherapies and expanded coverage of disease-specific scenarios |
| signal transduction and targeted therapy impact factor: Targeted Therapy in Translational Cancer Research Apostolia-Maria Tsimberidou, Razelle Kurzrock, Kenneth C. Anderson, 2015-12-21 Targeted Therapy in Translational Cancer Research for the Translational Oncology series provides a comprehensive overview of recent developments in our understanding of tumor biology, elucidates the roles of targets and pathways involved in carcinogenesis, and describes current state-of-the-art anticancer therapy, as well as the most promising areas of translational research and targeted therapy. Introduces cutting-edge ‘bench to bedside and back’ breakthroughs which have transformed the diagnosis, prognosis, and treatment of cancer Covers basic principles of targeted therapy, including immunotherapy and the roles of cancer stem cells, the microenvironment, angiogenesis, epigenetics, microRNAs, and functional imaging in precision medicine Summarises major advances in therapeutic management of hematologic malignancies and solid tumors using conventional therapy, targeted therapy, immunotherapy, or novel treatment modalities |
| signal transduction and targeted therapy impact factor: Journal of the National Cancer Institute , 2014 |
| signal transduction and targeted therapy impact factor: Drug Discovery Stories Bin Yu, Peng Zhan, 2024-10-25 Drug Discovery Stories: From Bench to Bedside presents a collection of cases on the development of highly successful pharmaceuticals. It delves into the realm of drug discovery, exploring the structural biology and biological functions of the sought-after targets. The book covers the identification of promising compounds, their transformation from hits to leads through meticulous optimization, and the elucidation of how key compounds interact with the target (in essence, providing invaluable insights for drug design). Additionally, it covers essential information such as the pivotal biological and PK data of lead compounds, any noteworthy clinical results, and a comprehensive overview of other candidate compounds.The field of drug discovery and development has experienced rapid evolution, with numerous new drugs receiving approval each year. While several books have been published on this subject, there is a pressing need for a new book series that accurately reflects the current advancements in drug discovery. This book aims to not only cater to the drug discovery community but also engage other communities involved in chemical biology, synthetic chemistry, and pharmacology. - Analyzes the drug discovery stories of different blockbuster drugs - Includes the newly approved drugs - Covers key aspects related to the drug development of the drugs |
| signal transduction and targeted therapy impact factor: Traditional and Herbal Medicines for COVID-19 Jen-Tsung Chen, 2024-11-11 Traditional and Herbal Medicines for COVID-19 explores promising ways to manage COVID-19, post-COVID, and long-COVID conditions. The management plans are based on anti-virus activity, anti-inflammatory activity, and diverse health benefits of traditional and herbal medicines through a comprehensive summarization of scientific literature by experts in the field. It presents views of the origin of SARS-CoV-2 and emerging variants and pathogenesis, and it proposes renewed strategies of diagnostics, vaccines, and therapies. Features Provides an in-depth analysis to illustrate the impact of traditional and herbal medicines on crucial protein targets responsible for the progress of SARS-CoV-2 infection and symptoms. Presents knowledge of SARS-CoV-2 and variants. Explores strategies to manage COVID-19, post-COVID, and long-COVID by applying traditional herbal medicines. Illustrates molecular aspects of anti-coronavirus activity from traditional herbal medicines. Features information on molecular mechanisms of target proteins involving COVID-19 infection and symptoms. Traditional and Herbal Medicines for COVID-19 serves as an ideal reference for researchers and experts in the fields of virology, epidemiology, drug discovery, and traditional herbal medicine. This book aligns with supporting the Sustainable Development Goals (SDGs) 2030 by the United Nations to establish “Good Health and Well-Being.” |
| signal transduction and targeted therapy impact factor: Genome Editing in Drug Discovery Marcello Maresca, Sumit Deswal, 2022-03-29 GENOME EDITING IN DRUG DISCOVERY A practical guide for researchers and professionals applying genome editing techniques to drug discovery In Genome Editing in Drug Discovery, a team of distinguished biologists delivers a comprehensive exploration of genome editing in the drug discovery process, with coverage of the technology’s history, current issues and techniques, and future perspectives and research directions. The book discusses techniques for disease modeling, target identification with CRISPR, safety studies, therapeutic editing, and intellectual property issues. The safety and efficacy of drugs and new target discovery, as well as next-generation therapeutics are also presented. Offering practical suggestions for practitioners and academicians involved in drug discovery, Genome Editing in Drug Discovery is a fulsome treatment of a technology that has become part of nearly every early step in the drug discovery pipeline. Selected contributions also include: A thorough introduction to the applications of CRISPRi and CRISPRa in drug discovery Comprehensive explorations of genome-editing applications in stem cell engineering and regenerative medicine Practical discussions of the safety aspects of genome editing with respect to immunogenicity and the specificity of CRISPR-Cas9 gene editing In-depth examinations of critical socio-economic and bioethical challenges in the CRISPR-Cas9 patent landscape Perfect for academic researchers and professionals in the biotech and pharmaceutical industries, Genome Editing in Drug Discovery will also earn a place in the libraries of medicinal chemists, biochemists, and molecular biologists. |
| signal transduction and targeted therapy impact factor: Handbook of Proteases in Cancer Sajal Chakraborti, 2024-12-17 This handbook provides comprehensive coverage of the application of proteases in cancer therapy. Proteases make up to two percent of the human genome and play a critical role in the tumor microenvironment. The book delves into the applications of natural, synthetic, and non-coding RNAs in cancer therapy. It highlights how effective targeting of relevant proteases can help in cancer diagnosis and treatment. It covers the systems biology and bioinformatics approach in cancer drug development. The book is meant for researchers and professionals in cancer research, biochemistry, and physiology. |
| signal transduction and targeted therapy impact factor: Cell Signalling John T. Hancock, 2017 Signaling within and between cells is one of the most important aspects of modern biochemistry and cell biology. An understanding of signalling pathways is vital to a wide range of biologists, from those who are investigating the causes of cancer, to those who are concerned about the impact of environmental pollutants on the ecosystem. The way cells adapt to changing environments, and the way cell dysfunction causes disease, is underpinned by cell signalling events. Cell Signalling presents a carefully structured and highly accessible introduction to this intricate and rapidly growing field. Starting with an overview of cell signalling and highlighting its importance in many biological systems, the book goes on to explore the key components of extracellular and intracellular signalling mechanisms, before examining how these components come together to create signalling pathways. A focus on common components and concepts, rather than mechanistic detail, allows the reader to gain a thorough understanding of the principles that underpin cell signalling. Online Resource Centre The Online Resource Centre to accompany Cell Signalling features: For students: - Links to useful websites For registered adopters of the text: - Journal Clubs: suggested research papers and discussion questions linked to topics featured in the book - Figures from the book in electronic format for use in lectures |
| signal transduction and targeted therapy impact factor: Nanobiotechnology Tridib Kumar Bhowmick, Kaylan Gayen, Sunil K. Maity, 2024-05-30 This book covers topics related to drug delivery, biomaterials, drug design, formulation development, nanoscience, and nanotechnology. It describes the fundamental concepts in nanotechnology and their different applications in biotechnology to solve engineering challenges and generate new areas of technological development. Nanobiotechnology: Applications of Nanomaterials in Biotechnology, Medicine, and Healthcare covers vast application areas that include medical science, material science, pharmaceutical science, and environmental science. Section 1 presents recent research updates on the different nanomaterials, which are promising in different medical and biotechnological applications. Applications of nanomaterials as bone replacement orthopedic implants have revolutionized the treatment of orthopedic surgery. Nanostructured polymeric materials have gained immense research attention as therapeutic carriers for the precise delivery of drugs at targeted sites. Nanocellulose is recognized as a promising green nanomaterial due to its renewability and abundance in nature. Scientific topics on the most recent scientific and technological advances and applications of different nanostructured materials are presented in this section. Section 2 focuses on the novel synthesis methods that are used extensively and are promising for large-scale production of inorganic and nanostructured materials. Section 3 covers the applications of nanotools in the treatment of different diseases, including cancers and genetic diseases. The increasing use of nanotechnology will bring changes in the manufacturing processes of nanomaterials. The applications of nanomaterials in the field of medical imaging and molecular detection are presented in section 4. This book will be useful for students, researchers, scientists, academicians, and industrial manufacturers to understand the importance and applicability of nanomaterials in the field of biotechnology and medical science. |
| signal transduction and targeted therapy impact factor: p53 in Breast Cancer Manzoor Ahmad Mir, 2024-12-24 p53 in Breast Cancer: Molecular Mechanisms, Clinical Implications, and Therapeutic Targets comprehensively reviews the role of p53 in breast cancer development, progression, and treatment. It explores the multifaceted functions of p53, from its fundamental connection to breast cancer and pathway mechanisms to its influence on cancer metabolism and the impact of mutational alterations. The initial chapters discuss the complex landscape of p53's involvement in cancer metabolism, the ramifications of its mutations, and its crucial role as a tumor suppressor. The subsequent chapters review the regulatory functions of p53 in cell death, DNA repair, genomic stability, and cell cycle dynamics, highlighting its interactions with transcription factors, DNA repair enzymes, and family members p63 and p73. It further reviews the regulation of mutant p53 via post-translational modifications and delves into the approaches to combat mutated p53, highlighting targeted therapies and efforts to overcome chemoresistance. The chapters also address the role of p53 biomarkers in diagnosis and prognosis, the optimization of treatment responses, and the impact of nutrition on p53 activity. This book is an important resource for oncology and molecular biology researchers. Key Features Provides a thorough examination of the p53 gene and its crucial involvement in breast cancer. Explores the critical implications of mutational alterations in p53 on the development and progression of breast cancer. Examines the role of p53 in managing apoptosis and contributing to DNA repair and genomic stability. Discusses the complex interactions of p53 with transcription factors, DNA repair enzymes, p63, and p73. Highlights the role of p53 as a biomarker in diagnosing and predicting breast cancer prognosis. |
| signal transduction and targeted therapy impact factor: Sinusoidal Cells in Liver Diseases Jordi Gracia-Sancho, 2024-04-09 Sinusoidal Cells in Liver Diseases: Role in their Pathophysiology, Diagnosis, and Treatment provides a state-of-the-art review on recent advances surrounding the role of liver sinusoidal cells (LSECs, HSCs, macrophages, and other non-parenchymal cells) in acute and chronic liver diseases. Coverage emphasizes disease pathophysiology, novel mechanisms, unmet clinical questions, development of biomarkers and treatment opportunities. By focusing on the role of sinusoidal cells in human liver diseases, this reference provides a comprehensive overview of the role of sinusoidal cells in acute and chronic liver diseases, in its pathophysiology and mechanisms, and in the development of novel biomarkers and new therapeutics. Cells of the liver vasculature play an essential role in the pathophysiology of acute and chronic liver diseases and are considered key therapeutic targets to treat most of human hepatopathies. Coverage in this reference includes the phenotypic changes occurring in liver vascular cells and how cells contribute to the development of microcirculatory dysfunction, fibrosis, inflammation, and liver failure. - Provides a comprehensive update on the role of sinusoidal cells in acute and chronic liver diseases - Covers our current understanding of the role of sinusoidal cells as therapeutic targets to improve liver diseases - Presents the latest research in the development of novel biomarkers of liver diseases that derive from sinusoidal cells |
| signal transduction and targeted therapy impact factor: Lung Cancer and Environmental Toxicants Kamal Dua, Gaurav Gupta, Ronan MacLoughlin, Sachin Kumar Singh, Asif Ahmad Bhat, 2025-05-23 Lung Cancer and Environmental Toxicants aims to explore the intricate relationship between lung cancer and environmental toxicants, shedding light on a hidden link that demands urgent attention. This groundbreaking book addresses a critical gap in the current literature by introducing a pioneering exploration of the interplay between lung cancer and environmental toxicants. Previous articles have not coalesced into a comprehensive examination of the complex connection between lung cancer development and the diverse array of environmental toxicants. This book delves into the latest scientific research and clinical findings to offer a clear way forward for healthcare workers to assess and treat lung cancer patients who may have been exposed to these substances. Lung Cancer and Environmental Toxicants provides a precise view of the impact of environmental toxicants on lung cancer, covering various aspects including epidemiology, molecular mechanisms, exposure pathways, and preventive measures. This unique and timely work will pave the way for a deeper understanding of the underexplored factors contributing to lung cancer incidence, offering novel insights into the role of various toxic substances in disease causation. This significant title will catalyze new avenues of research and awareness in the fields of oncology, environmental health, and public policy. - Unlocks the intricate nexus between lung cancer and environmental toxicants, offering an unprecedented exploration of complex mechanisms and interactions for advancing research in oncology and environmental health - Takes a global perspective on lung cancer and environmental toxicants, considering the prevalence of the disease and its causes in different regions of the world, as well as addressing the challenges faced by developing nations - Presents rigorous, evidence-based research on the effects of toxicants on the human lung, ensuring the book's indispensability |
| signal transduction and targeted therapy impact factor: Tumor-Targeting with Stimuli-Responsive Vesicular Nanocarriers Ankit Jain, Nishit Mody, Srinath Palakurthi, 2025-04-15 Tumour-Targeting with Stimuli Responsive Vesicular Nanocarriers: Basics to Emerging Applications not only acquaints scientists and science interns with the fundamental knowledge of the experimental aspects and state-of-the-art technology for vesicular carriers to equip their rational application in tumor targeting, but also provides a holistic understanding of regulatory concerns, patents, and clinical trials. In 15 chapters. this book provides basics and advances in stimuli-responsive vesicular carriers for tumor targeting based on findings outlined in highly organized tables, illustrative figures, and flow charts.With a focus on the extrapolation of bioengineering tools in the domain of vesicular carriers, stimuli-responsive features concerning tumors, drug delivery approaches, and associated challenges, it helps readers to define the major gaps in knowledge that can lead to significant scientific discoveries in therapy, diagnosis, and theragnosis of cancer. - Addresses the unmet needs and challenges confronted by nanotechnologists to foster collaboration of biologists, chemists, physicists, bioengineers, and clinicians - Provides an explicit account of vital aspects of PEGylation of these carriers and challenges for effective tumor targeting - Presents a need-of-hour discussion over regulatory concerns, clinical trials, and patents |
| signal transduction and targeted therapy impact factor: Diagnostic, Prognostic, and Therapeutic Role of MicroRNAs in Head and Neck Cancer Ashok Kumar, Neha Arya, Shikha Tiwari, Raju Khan, 2024-07-25 Early diagnosis of HNSCC can cause improved treatment, treatment response rates and reduction in mortality rates. Recently, miRNA-based diagnostics and therapeutics have gained considerable attention among the scientific community. MiRNAs are known to have great potential as biomarkers for early diagnosis, prediction, and prognosis of HNSCC, and play a role in development of targeted gene therapy.Diagnostic, Prognostic and Therapeutic Role of MicroRNAs in Head and Neck Cancer provides detailed information on various miRNA-based approaches for diagnosis, prognosis, and treatment of HNSCC. It encompasses various miRNA-based point of care diagnostics and drug delivery systems for HNSCC along with the information on the clinical trials of miRNAs for improved clinical outcomes in HNSCC patients. The book provides a comprehensive overview of currently available miRNAs associated with HNSCC and their extensive application for early diagnosis, prognosis, and treatment. This book will help scientists and clinicians to win the battle against HNSCC. - Covers the role of the tumor microenvironment in head and neck cancer - Provides information on oncogenic and tumor suppressor miRNAs dysregulated in HNSCC patients - Elucidates the role of miRNAs in metastasis, recurrence, and chemoresistance in HNSCC - Includes the current state-of-art in miRNA-based clinical trials for head |
| signal transduction and targeted therapy impact factor: The Fine Blueprint of Integrating Immunotherapy and Radiotherapy Lin-Lin Bu, Qiuji Wu, Bing Liu, 2025-04-11 This book provides a comprehensive overview of the principles and applications of immunotherapy and radiotherapy in the treatment of cancer. It covers the basic concepts of immunotherapy, immunology, radiation physics, radiobiology, and tumor biology, as well as their clinical aspects, such as patient selection, treatment planning, delivery techniques, toxicity management, outcome evaluation, and neoadjuvant approaches. The book also discusses the current challenges and future directions in the field, such as combining immunotherapy and radiotherapy, optimizing the timing and sequencing of treatments, developing novel biomarkers and predictive models, and implementing personalized and adaptive approaches. The book is intended for oncologists, radiation oncologists, medical physicists, radiation therapists, immunologists, researchers, students, and anyone interested in learning more about this rapidly evolving area of cancer therapy. |
| signal transduction and targeted therapy impact factor: Cell Therapy Nguyen Thanh Liem, Nicholas R. Forsyth, Michael Heke, 2025-05-12 This book provides an overview of cell-based therapy for human diseases including the definition, history, and clinical applications of human stem cells and their use in regenerative medicine. It covers human pluripotent stem cells (human embryonic stem cells and human induced pluripotent stem cells), mesenchymal stem/stromal cells, and hematopoietic stem cells, bone marrow mononuclear cells. In terms of clinical applications, this book also provides an update on recent human trials using these cells to treat various diseases, including neurological disorders, pulmonary dysfunctions, metabolic/endocrine-related diseases, frailty, and cancer treatment. In addition, it discusses the authors’ clinical trial experiences related to these conditions in a clinical setting to provide additional insight into regenerative medicine, especially cell-based therapy. The field of regenerative medicine has witnessed tremendous advancement in stem cell research and therapy in recent years, with thousands of preclinical studies supporting thousands of human clinical trials conducted worldwide. Emerging evidence in regenerative medicine and stem cell research suggests the treatments are safe, whereas their therapeutic potential, effectiveness, and mode of action require deeper investigation. It is important to introduce the science behind stem cell-based therapy to patients, clinicians, and researchers to further enhance understanding of responsible clinical conduct and so to educate and thus prevent the further emergence of unregulated, deceitful stem cell clinics solely operating for the sake of profit. |
| signal transduction and targeted therapy impact factor: Targeting Signaling Pathways in Solid Tumors Part C , 2024-10-11 Targeting Signaling Pathways in Solid Tumors, Part C, Volume 389 in the International Review of Cell and Molecular Biology series, highlights new advances in the field, with this new volume presenting interesting chapters on topics such as Drugging the Undruggable: Advances in Targeting KRAS Signaling in Solid Tumors, Emerging Trends in Gastrointestinal Cancers: Targeting Developmental Pathways in their Carcinogenesis and Tumor Progression, Importance of targeting various cell signaling pathways in solid cancers, Targeting signaling pathways in cancer stem cells: a potential approach for developing novel anticancer therapeutics, Factors affecting heterogeneity in breast cancer microenvironment: A narrative review, and much more.Additional sections cover Exploring TLR Signaling Pathways as Promising Targets in Cervical Cancer: The Road Less Travelled - Provides the latest information on cancer research - Offers outstanding and original reviews on a range of cancer research topics - Serves as an indispensable reference for researchers and students alike |
| signal transduction and targeted therapy impact factor: Smart Drug Delivery Systems , 2024-08-21 Chemotherapeutic strategies are fundamental for treating diseases like cancer, which metastasizes rapidly to healthy tissues. However, these drugs, being nonspecific, may harm both the diseased as well as the healthy tissues. Rapid clearance, low uptake, and uneven distribution of the payloads at target sites result in poor biodistribution. To address the emerging challenges of off-target accumulation and patient noncompliance, it is crucial to selectively deliver therapeutic agents to target sites, release the loaded cargo efficiently, and remove the chemotherapeutic agents from the system without triggering an immune response. The advent of smart targeting methods has revolutionized drug delivery systems (DDS). Stimuli-responsive smart DDS can release drugs in response to pH, light, redox, magnetic fields, and hyperthermia, marking the future of translational medicine. Exosomes and phytosomes are innovative drug delivery platforms that have brought about a paradigm shift in DDS. Theranostic agents, which combine diagnostic and therapeutic functions, represent a significant advancement in personalized medicine. These agents allow real-time assessment of drug biodistribution, release, and therapeutic outcomes. Theranostic probes, particularly nanoparticles with drug carrier and imaging capabilities, have transformed cancer therapy by enabling precise imaging at tumor sites. This book explores drug delivery strategies for therapeutic products including vitamins, emphasizing the delivery of live cell therapies. It also highlights nanostructured systems tailored for smart drug delivery and theranostic medicines, showcasing promising advancements in this emerging field. |
| signal transduction and targeted therapy impact factor: Medical-Surgical Nursing - E-Book Donna D. Ignatavicius, M. Linda Workman, Cherie Rebar, 2017-09-09 Awarded second place in the 2018 AJN Book of the Year Awards in Medical-Surgical Nursing! Healthcare is evolving at an incredible pace and with it, the roles and responsibilities of the medical-surgical nurse. Ensure you are fully equipped to thrive and adapt in this ever-changing nursing environment with Ignatavicius, Workman, and Rebar's Medical-Surgical Nursing: Concepts for Interprofessional Collaborative Care, 9th Edition. This trendsetting text not only covers all essential adult health knowledge, but also reinforces the application, conceptual thinking, and clinical judgment skills that today’s nurses need to stay one step ahead in delivering exceptional patient care, no matter the environment. As with previous Iggy editions, you’ll find a unique collaborative care approach to adult health nursing, a thorough integration of QSEN competencies, extensive NCLEX® Exam preparation, and a direct, reader-friendly tone throughout the text. This ninth edition incorporates two emerging and complementary trends — the Core Competencies for Interprofessional Collaborative Practice and a more conceptual approach teaching and learning — areas that will ground you in how to think like a nurse and how to apply the knowledge you gain from the text to clinical practice. There are a lot of med-surg nursing texts out there, but there’s only one that combines all the information, concepts, and on-the-job realities in a way that makes perfect sense: Iggy! Trendsetting QSEN integration emphasizes patient safety and evidence-based practice with Nursing Safety Priority boxes, including Drug Alerts, Critical Rescues, and Action Alerts. UNIQUE! Emphasis on clinical judgment helps you develop skills in clinical reasoning and clinical decision-making when applying concepts to clinical situations. Strong emphasis on NCLEX Exam preparation includes chapter-opening Learning Outcomes and chapter-ending Get Ready for the NCLEX Examination! sections organized by NCLEX Client Needs Categories, plus NCLEX Examination Challenge questions, with an answer key in the back of the book and on the Evolve companion website. Exceptionally readable content features shorter sentences, straightforward vocabulary, and a direct, reader-friendly writing style. |
| signal transduction and targeted therapy impact factor: Targeted Therapy of Acute Myeloid Leukemia Michael Andreeff, 2014-11-20 This book provides an unprecedented overview of Targeted Therapies for acute myeloid leukemias. It aims at an almost comprehensive coverage of the diverse therapeutic strategies that have been developed during the last decade and are now being evaluated in early clinical trials. Paired and authoritative chapters by leading research scientists and clinicians explain basic concepts and clinical translation of topics that include the underlying genetic and proteomic abnormalities of AML, the development of novel nucleoside analogues, the roles of microRNAs, apoptosis regulators Bcl-2 and p53 and of critical cell signaling proteins such as PIM, FLT3, Raf/MEK, PI3K/AKT/mTOR and aurora kinases. Chapters on epigenetic mechanisms, nuclear receptors, cell surface antigens, the hypoxic leukemia microenvironment, stem cells and leukemia metabolism provide insights into leukemia cell vulnerabilities. Cell therapies utilizing T-, NK- and mesenchymal stem cells and progress in hematopoietic transplantation strategies round up this overview of the multi-dimensional therapeutic landscape in which leukemia specialists develop treatment strategies that are expected to make leukemia history in the near future. |
| signal transduction and targeted therapy impact factor: Cancer Therapy Surendra Nimesh, Nidhi Gupta, Guilherme Carneiro, 2024-05-30 While there have been a large number of ongoing research projects and publications on the treatment of cancer, there is a limited number of books related to nanotechnology with emphasis on polymeric nanoparticles in cancer therapy. The book, covering all of the recent research work done on this basis, enlightens researchers and students with the benefits of polymeric nanomaterials in cancer. This book provides exhaustive knowledge on polymeric nanoparticles and cancer. - Provides a complete overview of the application of different polymeric nanoparticles in cancer therapeutics: from characterization of nanoparticles to in vitro and in vivo studies. - Contains a detailed description of the delivery of therapeutic molecules with different polymers realized with nanomedicine in cancer therapeutics. - Discusses newly developed promising polymers in cancer. - Describes polymeric nanoparticle and their role in theranostics pertaining to cancer. - Reviews clinical relevance of different polymeric formulations in the field of cancer |
| signal transduction and targeted therapy impact factor: Targeting Signaling Pathways in Solid Tumors Part A , 2024-04-23 Targeting Signaling Pathways in Solid Tumors, Part A, Volume 385 in the International Review of Cell and Molecular Biology series, highlights new advances in the field, with this new volume presenting interesting chapters on topics such as Drugging the Undruggable: Advances in Targeting KRAS Signaling in Solid Tumors, Emerging Trends in Gastrointestinal Cancers: Targeting Developmental Pathways in their Carcinogenesis and Tumor Progression, Importance of targeting various cell signaling pathways in solid cancers, Targeting signaling pathways in cancer stem cells: a potential approach for developing novel anticancer therapeutics, Factors affecting heterogeneity in breast cancer microenvironment: A narrative review, and much more.Additional sections cover Exploring TLR Signaling Pathways as Promising Targets in Cervical Cancer: The Road Less Travelled - Provides the latest information on cancer research - Offers outstanding and original reviews on a range of cancer research topics - Serves as an indispensable reference for researchers and students alike |
| signal transduction and targeted therapy impact factor: International Journal of Applied Sciences: Current and Future Research Trends (IJASCFRT) , 2021-12-31 |
| signal transduction and targeted therapy impact factor: Cancer Biology and Advances in Treatment Phuc Van Pham, 2020-10-14 This new series, based on a bi-annual conference and its topics, represents a major contribution to the emerging science of cancer research and regenerative medicine. Each volume brings together some of the most pre-eminent scientists working on cancer biology, cancer treatment, cancer diagnosis, cancer prevention and regenerative medicine to share information on currently ongoing work which will help shape future therapies. These volumes are invaluable resources not only for already active researchers or clinicians but also for those entering these fields, plus those in industry. Cancer Biology and Advances in Treatment is a proceedings volume which reflects papers presented at the 3rd bi-annual Innovations in Regenerative Medicine and Cancer Research conference; taken with its companion volume Tissue Engineering and Regenerative Medicine and Stem Cells: Biology and Engineering it provides a complete overview of the papers from that meeting of international experts. |
| signal transduction and targeted therapy impact factor: Biotechnologies for Gene Therapy Yang H. Yun, Kristine E. Yoder, 2022-06-02 The purpose of this book is to highlight some of latest developments and applications of CRISPR, RNA, and DNA to treat diseases ranging from cancers to cardiovascular and degenerative disorders. It also features innovations of the delivery methods for nucleic acids ranging from nanodevices made from DNA and pseudo amino acids to viral vectors. This is an ideal book for academics, clinicians, and students interested in gene therapy. |
| signal transduction and targeted therapy impact factor: Molecular Markers and Targeted Therapy for Hepatobiliary Tumors, volume I.A Yunfei Xu, Zongli Zhang, Hongda Liu , Xuesong Gu, 2024-07-26 Hepatobiliary tumor, mainly including hepatocellular carcinoma, cholangiocarcinoma and gallbladder cancer, is a group of highly aggressive malignancies. Hepatocellular carcinoma, cholangiocarcinoma and gallbladder cancer have different biological characters, histopathological traits, and treatment strategies, but have similar clinical features such as silent early symptom and extremely poor prognosis. The diagnostic, predictive or prognostic tumor biomarkers of hepatobiliary cancers are in unmet need. In contrast to the poor outcome, the treatment options to hepatobiliary cancers are very limited. It is still controversial about the effects of chemotherapy and radiotherapy of hepatobiliary cancer. FDA-approved targeted drugs are only Sorafenib and Lenvatinib for hepatocellular carcinoma, and Pemigatinib for cholangiocarcinoma. Unfortunately, these drugs are only effective for 5%-30% patients. Therefore, more attention should be called upon on investigating effective biomarkers and drug targets, stratifying high-risk patients, guiding precise treatments, and developing therapeutic strategies for hepatobiliary cancers. This Research Topic aims at discussing the current knowledge and proceedings of diagnostic, predictive and prognostic tumor biomarkers in hepatobiliary cancer, and presenting the recent advances on new drug targets and potential targeted therapies of hepatobiliary cancer. We welcome submissions of Review, Mini-Review, Clinical Trial and Original Research articles covering, but not limited to, the following topics: 1. new diagnostic/prognostic factors, biomarkers and/or risk factors in hepatobiliary tumors 2. new drug targets, and oncogenic or tumor suppressive molecular mechanism of the novel targets 3. new intervention or targeted therapy in hepatobiliary tumors 4. new findings of bioinformatics or high-throughput methods such as mass spectrometry and genome-wide association studies or which may help screen the potential biomarkers of hepatobiliary tumors 5. clinical studies such as cohort study or RCT to identify new risks or treatment therapies in hepatobiliary tumors 6. basic, pharmacological, preclinical or clinical study of potential drugs targeting hepatobiliary tumors Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic. |
Signal >> Download Signal - Signal Messenger
Download Signal for Android, iOS, Linux, macOS, and Windows.
Signal (software) - Wikipedia
Signal is an American open-source, encrypted messaging service for instant messaging, voice calls, and video …
Installing Signal – Signal Support
Fast, simple, secure. Signal is privacy that fits in your pocket (or on your desk). Download Signal here or follow the …
What is Signal? The private chat app is only private if you …
Mar 25, 2025 · While Signal offers more privacy perks compared to other messaging apps, it’s not meant for …
Signal Private Messenger - Apps on Google Play
Jun 9, 2025 · Signal is a messaging app with privacy at its core. It is free and easy to use, with strong end-to-end …
Signal >> Download Signal - Signal Messenger
Download Signal for Android, iOS, Linux, macOS, and Windows.
Signal (software) - Wikipedia
Signal is an American open-source, encrypted messaging service for instant messaging, voice calls, and video calls. [14] [15] The instant messaging function includes sending text, voice …
Installing Signal – Signal Support
Fast, simple, secure. Signal is privacy that fits in your pocket (or on your desk). Download Signal here or follow the installation steps for your platform. Android; iOS; Linked Desktop; Signal …
What is Signal? The private chat app is only private if you ...
Mar 25, 2025 · While Signal offers more privacy perks compared to other messaging apps, it’s not meant for sharing classified government and military information. Some factors are beyond the …
Signal Private Messenger - Apps on Google Play
Jun 9, 2025 · Signal is a messaging app with privacy at its core. It is free and easy to use, with strong end-to-end encryption that keeps your communication completely private. • Send texts, …
What is Signal? How to use the encrypted messaging app
Apr 25, 2023 · The Signal messaging app uses end-to-end encryption so that your texts, calls, videos, files, and location remain private. Here's how to use it.
What Is Signal, and Why Is Everyone Using It? - How-To Geek
Mar 4, 2022 · Signal is a secure encrypted messaging app. Think of it as a more private alternative to WhatsApp, Facebook Messenger, Skype, iMessage, and SMS. Here's why you …
